or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    GTHX D G1 Therapeutics, Inc. 0.00
    CASI D CASI Pharmaceuticals, Inc. -2.86
    MURA D Mural Oncology plc -0.59
    AEMD D Aethlon Medical, Inc. 4.90
    MRKR D Marker Therapeutics, Inc. 5.02
    MEIP D MEI Pharma, Inc. -1.07
    BMRN D BioMarin Pharmaceutical Inc. 1.28
    ORIC F Oric Pharmaceuticals, Inc. 5.15
    CLDX F Celldex Therapeutics, Inc. 3.05
    PRPO F Precipio, Inc. -1.51
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
    Related Stock Lists: Cancer Medicine Solid Tumors Biopharmaceutical Cancer Treatment Immunotherapy Virotherapy Biotechnology Clinical Medicine Oncology Ovarian Cancer Autoimmune Disease Biology Breast Cancer Clinical Development Disease Her2 Her2/Neu Immune System Immunology

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 3.88
    PBE C PowerShares Dynamic Biotech & Genome 3.76
    FBT C First Trust Amex Biotech Index Fund 3.15
    GDOC D Goldman Sachs Future Health Care Equity ETF 2.64
    XBI D SPDR S&P Biotech ETF 2.41
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare FBT to GDOC Compare GDOC to XBI Compare PBE to XBI

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        Nov 24 MURA Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
        Nov 22 MEIP Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
        Nov 21 BMRN Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 BMRN BioMarin: Challenges Mount, But Sale Rumors Make For A Risky 'Buy' Call
        Nov 21 BMRN Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
        Nov 20 MURA Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 19 BMRN BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
        Related Stock Lists: Cancer Medicine Solid Tumors Biopharmaceutical Cancer Treatment Immunotherapy Virotherapy Biotechnology Clinical Medicine Oncology Ovarian Cancer Autoimmune Disease Biology Breast Cancer Clinical Development Disease Her2 Her2/Neu Immune System Immunology
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags